Skip to main content
Clinical Trials/NCT06804408
NCT06804408CompletedNot Applicable

Unpacking the "Mind" and "Body" Pathways of the Antidepressant Effect of Qigong in Older Adults: A Pilot Study

The Hong Kong Polytechnic University1 site in 1 country106 target enrollmentStarted: May 1, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
106
Locations
1
Primary Endpoint
Depressive symptoms

Study Overview

Brief Summary

The goals of the study are to explore the neurobiological mechanisms and cognitive benefits of qigong in older adults. The main research questions are:

  • Does 12-week qigong training lead to significant enhancement in serum adiponectin, serum BDNF and significant reduction in salivary cortisol?
  • Does 12-week qigong training bring significant improvement in global cognitive function?

Participants are older adults aged 60 or above. They were randomly assigned to qigong training, mindfulness training, physical exercise training, or wait-list which all last for 12 weeks. Their changes before and after the 12-week period in depressive symptoms, neurobiological markers, and cognitive functions are assessed.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
60 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •60 years or older;
  • •With mild or severer levels of depressive symptoms as indicated by the Geriatric Depression Scale (GDS-8) scores of 5 or above, or Depression Anxiety and Stress Scale-21 (DASS-21) depression subscale scores of 4 or above
  • •Self-identified as physically stable and without life-threatening diseases.

Exclusion Criteria

  • •With a history of practicing or receiving training of any form of mind-body or regular exercises (including tai chi, yoga, and qigong, or regular physical activity > 3 times/week) during the month prior to study enrollment
  • •Having changed medications or the dose of medications prescribed for their health condition in the month prior to study enrollment
  • •With severe cognitive or language impairment as defined as a score of less than 21 on Montreal Cognitive Assessment (MoCA-5min)
  • •Undergoing electroconvulsive therapy, psychotherapy, or psychoeducation for a psychological or psychiatric condition
  • •Unable to demonstrate satisfactory standing balance.

Arms & Interventions

Qigong

Experimental

12-week training of Baduanjin (or named Eight-Section Brocades), with two sessions per week. Each session lasts for 60 min.

Intervention: Qigong (Behavioral)

Mindfulness-based Training

Active Comparator

12-week training of mindfulness-based breathing, walking, and stretching practices, with two sessions per week. Each session lasts for 60 min.

Intervention: Mindfulness-based training (Behavioral)

Low-to-moderate Intensity Physical Exercise

Active Comparator

12-week training of stretching, flexibility exercise, and balance exercise, with two sessions per week. Each session lasts for 60 min.

Intervention: Low-to-moderate intensity physical exercise (Behavioral)

Waitlist

No Intervention

No training while the other three group are receiving training. Participants of this group are allowed to have Qigong, Mindfulness-based Training, or Low-to-moderate Intensity Physical Exercise after they complete all the assessments.

Outcomes

Primary Outcomes

Depressive symptoms

Time Frame: Baseline and post-intervention (12 weeks after baseline)

The eight-item Patient Health Questionnaire

Global cognitive function

Time Frame: Baseline and post-intervention (12 weeks after baseline)

Montreal Cognitive Assessment

Secondary Outcomes

  • Inhibitory control(Baseline and post-intervention (12 weeks after baseline))
  • ERP N2 amplitude(Baseline and post-intervention (12 weeks after baseline))
  • ERP P3 amplitude(Baseline and post-intervention (12 weeks after baseline))
  • Serum adiponectin(Baseline and post-intervention (12 weeks after baseline))
  • Serum BDNF(Baseline and post-intervention (12 weeks after baseline))
  • Salivary cortisol(Baseline and post-intervention (12 weeks after baseline))
  • Attention(Baseline and post-intervention (12 weeks after baseline))
  • Working memory(Baseline and post-intervention (12 weeks after baseline))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

TSANG Hector Wing-Hong

Professor

The Hong Kong Polytechnic University

Study Sites (1)

Loading locations...

Similar Trials